Scramble is a street drug that originated in Baltimore, Maryland, as heroin mixed with cutting agents like quinine and lactose, sold cheaply in gelatin capsules. What once had a rough but known recipe has become something far less predictable: users and researchers alike report that scramble now routinely contains fentanyl, benzodiazepines, crushed prescription pills, and veterinary sedatives, sometimes with little or no actual heroin at all. Understanding what scramble is today requires understanding how dramatically it has changed from what it was even a decade ago.
How Scramble Became Baltimore’s Street Drug
Baltimore has long had an unusual heroin market split into two distinct product lines. One is called “Raw,” believed to be Colombian in origin and relatively pure, sold in small glass vials for $20 or more. The other is scramble, which traditionally consisted of raw heroin blended with quinine and lactose to stretch the supply, packaged in gelatin capsules and sold at a much lower price point of $5, $6, or $10.1PubMed Central. Sold As Heroin: Perceptions and Use of an Evolving Drug in Baltimore, MD This two-track system is unusual in the American drug market, where most cities have a single dominant heroin type.
The lower price made scramble accessible to people who couldn’t afford raw heroin, and it developed its own following. Users described favoring scramble for its “rushing” sensation, referred to locally as its “call,” a rapid and intense onset that some preferred even when raw heroin was available.1PubMed Central. Sold As Heroin: Perceptions and Use of an Evolving Drug in Baltimore, MD That rushing quality likely came from the quinine used as a cutting agent, which can produce its own noticeable physiological effects when injected. Over time, scramble gained market share in Baltimore’s drug economy, becoming the more commonly available product in many neighborhoods.
What Scramble Actually Contains Today
The traditional scramble recipe of heroin, quinine, and lactose has mostly vanished. Users interviewed in research studies reported that scramble had become a wildly variable product, with some concluding it was no longer “heroin” at all. People described the appearance, the speed of onset, the duration of the high, and the overall effect changing unpredictably from one batch to the next. Fentanyl, benzodiazepines, and crushed opioid pills were all mentioned as suspected additives or replacements.1PubMed Central. Sold As Heroin: Perceptions and Use of an Evolving Drug in Baltimore, MD
Lab testing has confirmed just how far the gap has widened between what people think they’re buying and what they’re actually getting. A statewide drug checking program in Maryland analyzed nearly 800 samples submitted by people who use drugs. Only about one in five samples matched what the person expected them to contain. Roughly a third of samples were intended to be heroin, but fewer than 2 percent of all samples actually tested positive for heroin. Meanwhile, xylazine, a veterinary tranquilizer, turned up in over 57 percent of samples despite being expected in fewer than 2 percent. Cocaine appeared in about a quarter of samples, including in some that were supposed to contain only opioids, and benzodiazepines showed up in samples intended to be purely opioids or stimulants.2Drug and Alcohol Dependence. Comparison of anticipated and detected drug contents in samples submitted to a statewide drug checking program in Maryland, USA
That data paints a striking picture. A person buying what they believe is heroin in Maryland, whether it’s labeled scramble or anything else, has a very high chance of receiving a product that contains no heroin and a very high chance of getting xylazine they didn’t ask for. The term “scramble” at this point describes a market category and a price point more than a consistent chemical product.
Why the Composition Changes So Drastically
The shift away from heroin in scramble mirrors a broader change in North American drug markets. Illicitly manufactured fentanyl is cheaper to produce, easier to transport in small quantities, and far more potent by weight than heroin. For dealers, replacing heroin with fentanyl or fentanyl mixed with inert fillers is simply more profitable. The people filling gelatin capsules at the retail level may not even know what the powder they received from their supplier actually contains. Each hand the product passes through is another opportunity for additional cutting, substitution, or contamination.
The result is that scramble’s composition can vary not just between dealers but between batches from the same dealer, even between capsules from the same batch. A user who takes one capsule and survives might take a second from the same purchase and overdose, because fentanyl wasn’t mixed evenly into the powder. This “hot spot” problem, where tiny clumps of fentanyl concentrate unpredictably in a batch of filler, is one of the deadliest features of the modern supply.
The Overdose Crisis Scramble Helped Fuel
Baltimore’s overdose numbers track the transformation of scramble. After falling to 76 heroin-related overdose deaths in 2011, the city saw that number climb to 260 in 2015 and then to 454 in 2016. Fentanyl-related deaths rose even more steeply, going from single digits to 182 in 2015 and 419 in 2016.1PubMed Central. Sold As Heroin: Perceptions and Use of an Evolving Drug in Baltimore, MD Those two trend lines crossing tells you exactly what happened: fentanyl was replacing heroin in the supply while users still thought they were buying heroin.
Scramble’s low price makes it especially dangerous in this context. It attracts people with less money, including younger users and people early in their opioid use who haven’t developed the tolerance that longer-term users have. A person with low tolerance who buys a $5 capsule expecting weak, heavily cut heroin and instead gets fentanyl faces a serious risk of respiratory failure. The very feature that made scramble popular in the first place, its affordability, now makes it one of the riskiest purchases in the illicit drug market.
The Xylazine Problem
One of the most alarming additions to the scramble supply is xylazine, sometimes called “tranq” on the street. Xylazine is a sedative approved only for veterinary use. It works through a completely different mechanism than opioids, which means naloxone (Narcan) cannot reverse its effects the way it reverses an opioid overdose.3Current Pain and Headache Reports. Xylazine: A Drug Adulterant of Clinical Concern When someone who has taken a xylazine-laced product stops breathing, naloxone will address the opioid component but may leave the person still dangerously sedated.
Xylazine’s physical effects include slowed heart rate, an initial spike in blood pressure followed by a drop, irregular heartbeat, loss of coordination, slurred speech, heavy sedation, and depressed breathing.3Current Pain and Headache Reports. Xylazine: A Drug Adulterant of Clinical Concern The sedation can be prolonged, leaving users unconscious in unsafe positions for extended periods. This prolonged immobility contributes to another well-documented problem: severe skin ulcers and wounds, sometimes referred to as “tranq wounds,” that can develop even at injection sites far from the wound location. These wounds are difficult to treat, frequently become infected, and in severe cases have led to amputations.
The Maryland drug checking data showing xylazine in over half of all tested samples underscores how deeply embedded it has become in the supply.2Drug and Alcohol Dependence. Comparison of anticipated and detected drug contents in samples submitted to a statewide drug checking program in Maryland, USA Almost nobody buying drugs in that study expected xylazine to be present, yet it was the most commonly detected substance. People using scramble in Baltimore are almost certainly being exposed to xylazine regularly, whether they know it or not.
Why Users Cannot Judge Safety by Appearance
One of the most persistent and dangerous assumptions in street drug use is that experienced users can assess a product’s strength or safety by looking at it, smelling it, or tasting a small amount. With scramble, this was never entirely reliable, but today it is essentially impossible. The same research that documented scramble’s evolution found that users described dramatic and inconsistent changes in the drug’s appearance from one purchase to the next, and that these visual differences did not correspond predictably to the drug’s strength or contents.1PubMed Central. Sold As Heroin: Perceptions and Use of an Evolving Drug in Baltimore, MD
Fentanyl is active in microgram quantities, far below anything visible to the naked eye. A capsule of scramble could look like a weak, heavily diluted product and still contain a lethal dose of fentanyl concentrated in one corner of the powder. The color, texture, and smell of the filler material tell you almost nothing about what active substances are present or how much of them are there. This makes every purchase a gamble in a way that older versions of scramble, however risky, were not.
Fentanyl Test Strips and Their Limits
Fentanyl test strips have emerged as one of the most accessible harm reduction tools for people who use drugs. These single-use immunoassay strips can detect fentanyl and several of its analogues in a dissolved drug sample. Studies have found them to be highly sensitive and specific, catching fentanyl in 96 to 100 percent of positive samples and correctly identifying fentanyl-free samples 90 to 98 percent of the time. They can also detect analogues like acetylfentanyl and furanylfentanyl.4PubMed Central. Use of Rapid Fentanyl Test Strips Among Young Adults Who Use Drugs
But the strips have real shortcomings that matter for scramble users. They indicate only whether fentanyl is present or absent, not how much. Given that nearly all of the opioid supply in areas like Maryland now contains fentanyl, a positive result is almost guaranteed and doesn’t help a user distinguish between a moderately strong dose and a lethal one. The strips also cannot detect xylazine, benzodiazepines, or other non-opioid adulterants that make up an increasing share of scramble’s contents.
There are also quality control issues with the strips themselves. Research has found meaningful lot-to-lot variability in how the strips perform, which makes it difficult to give users consistent instructions about how to interpret results. One batch of strips might perform excellently while the next batch from the same manufacturer is less reliable.5PubMed Central. Testing the test strips: laboratory performance of fentanyl test strips Harm reduction programs have pushed for more sophisticated drug checking services to complement personal test strip use, including spectrometry-based services that can identify multiple substances and give rough quantitative estimates.
Contamination Risks Beyond Intentional Additives
The adulterants in scramble are not limited to drugs added for their psychoactive effects. Illicit drug production has no quality controls, and the substances used as cutting agents can introduce contaminants that no one in the supply chain intended. Research on illicit drugs has found toxic metals like lead present in analyzed samples, with concentrations varying widely depending on the drug type and origin.6Journal of Psychoactive Drugs. The Texture of Psychoactive Illicit Drugs in Iran: Adulteration with Lead and other Active Pharmaceutical Ingredients While that particular research focused on drugs outside the United States, the principle applies broadly: unregulated production environments introduce risks that go beyond the drugs themselves.
For scramble users who inject, these contaminants create an additional layer of danger. Injecting lead-contaminated material can cause acute lead poisoning, with symptoms that include abdominal pain, confusion, and seizures. Other common cutting agents like mannitol, sorbitol, or starch can cause vascular damage when injected. And because scramble passes through multiple intermediaries between production and sale, each step introduces opportunities for new contaminants to enter the product from dirty surfaces, repurposed containers, or previously used equipment.
How Scramble Differs from Other Street Drug Labels
Every region has its own slang for illicit drug products, and it’s worth understanding what makes scramble distinct. In most American cities, heroin is sold as a single product type, and while purity varies, the market doesn’t maintain two recognized categories the way Baltimore does with raw and scramble. The scramble label communicates specific expectations: cheaper, cut, sold in capsules rather than bags or vials, and with that characteristic rushing onset. Other cities might have terms for particularly weak or adulterated heroin, but they don’t have a product with its own name, packaging format, and dedicated customer base in the way scramble has existed in Baltimore for decades.
The scramble label also creates a false sense of familiarity. Someone who has been buying scramble for years may feel they understand the product, know what to expect, and can gauge their dose accordingly. But because the underlying contents have changed so radically, that accumulated knowledge is now actively misleading. The name stays the same while the product underneath rotates. A $5 scramble capsule in 2010 and a $5 scramble capsule today share a name and a price and almost nothing else.
Who Uses Scramble
Scramble’s user base has historically centered in Baltimore’s lower-income neighborhoods, where the drug’s low price point makes it more accessible than costlier options. But characterizing scramble use as limited to any single demographic misses the picture. Opioid use disorder cuts across income levels, and people with more resources may start with prescription pills or raw heroin and eventually turn to scramble when finances tighten, when their tolerance rises and they need to use more frequently, or simply when scramble is what’s available in their neighborhood on a given day.
The people most vulnerable to scramble’s risks are those who use alone, who lack access to naloxone, or who are unaware that the product they’re buying likely contains fentanyl and xylazine rather than heroin. People recently released from incarceration are at particularly high risk, because their tolerance drops during a period of forced abstinence, and a dose that would have been manageable before now becomes potentially fatal, especially when the substance is stronger than expected. Anyone who resumes use after a break, whether from incarceration, hospitalization, or an attempt to quit, faces a similar mismatch between their tolerance and the potency of the current supply.
The Role of Drug Checking Programs
Maryland has been at the forefront of statewide drug checking, partly because the severity of the crisis in Baltimore demanded it. Programs that allow people to submit samples anonymously for lab analysis serve two purposes: they give individual users information about what they’ve purchased, and they generate surveillance data that public health agencies can use to track what’s circulating in the supply. The finding that only about one in five samples matched expectations tells harm reduction workers and emergency responders what they’re dealing with in real time.2Drug and Alcohol Dependence. Comparison of anticipated and detected drug contents in samples submitted to a statewide drug checking program in Maryland, USA
These programs face challenges. Turnaround time matters: if a person submits a sample but doesn’t get results for days, they may have already used the product. Portable spectrometry devices can deliver results in minutes, but they’re expensive and require trained operators. Fentanyl test strips offer immediacy but, as noted, tell you very little about what else is in the sample. The ideal system combines rapid on-site testing with laboratory follow-up, but building that infrastructure requires sustained funding and political will.
The data from these programs has also reshaped how public health officials talk about the drug supply. Rather than framing the crisis as a “heroin epidemic” or even a “fentanyl epidemic,” the evidence increasingly points to a polydrug contamination problem in which any street purchase may contain multiple active substances that interact in unpredictable ways. Scramble, with its long history of intentional adulteration now compounded by unintentional contamination and wholesale substance replacement, is an especially clear example of that broader pattern.